Personalized symbiontic therapy for children with functional digestive disorders

The aim of the study was to identify the features of the influence of autoprobiotic and probiotic E. faecium strains on clinical and laboratory parameters in children with functional gastroenterological pathology.

Patients and methods. In the period 2020–2021. 35 children over 3 years of age with functional gastrointestinal disorders (FGID) were observed on an outpatient basis, who were prescribed an autoprobiotic or probiotic strain E. faecium for therapeutic purposes and recommended a diet.
The study protocol provided for clinical and anamnestic screening, FGID diagnostics; analysis of coprograms and assessment of the composition of the intestinal microbiota in children before and after a course of probiotics. The study of intestinal microbiota was carried out by RT-PCR in feces using a set of primers “Colonoflor”. One patient was excluded from the study due to refusal to take the autoprobiotic.
The rest of the patients formed two groups: group 1 (n = 16)—children who received the autoprobiotic strain and group 2 (n = 18)—children who received the conditionally “reference” strain E. faecium L3. Probiotics were used in the form of a liquid form (which is a starter culture based on soy protein isolates containing 10⁹  CFU in 1 ml) at a dose of 25 ml 2 times a day for 10 days.
The results of using probiotic strains were evaluated on the basis of data from a survey of parents about the state of children and the dynamics of clinical manifestations, as well as changes in the values of indicators of coprograms and the composition of the intestinal microbiota.
Statistical processing of the results was carried out using Student’s t-test, Mann-Whitney U-test; Wilcoxon test. The results were considered reliable at a significance level of p <0.05.

Results. Studies of the effect of prescribing E. faecium L3 strain and an autoprobiotic strain to children with FROP revealed a positive effect on the clinical symptoms of the disease (in 29.4% and 25%, respectively) in the absence of undesirable side effects. Analysis of the dynamics of coprograms revealed an equivalent positive dynamics in the form of improvement in most of the studied stool characteristics. The study of the composition of the intestinal microbiota in the observed children revealed a low level of Lactobacilli and Enterococcus before and after the administration of probiotics. After the course of the E. faecium L3 strain, a significant increase in the content of F. prausnitzii was noted. The use of an autoprobiotic strain contributed to a significant decrease in the frequency of isolation of conditionally pathogenic bacteria in large numbers

Conclusion. The course appointment of autoprobiotic and probiotic E. faecium strains in children with FGID has a positive effect on clinical symptoms, improvement of most coprogram indices and normalization of the intestinal microbiota composition.

1. Kapustin A.V., Khavkin A. I., Izachik Yu. A. Funktsional’nyye zabolevaniya organov pishchevareniya u detey. Opyt al’ternativnogo lecheniya. [Functional diseases of the digestive system in children. Experience with alternative treatment]. Almaty. “Kazakhstanskaya pravda”, 1994. 191 p. (In Russ).

2. Belmer S.V., Khavkin A. I., Pechkurov D. V. Functional disorders of the digestive system in children. Diagnostic and Treatment Principles. Moscow. “GEOTAR-Media” Publ., 2018, 160 p. (In Russ)

3. Omelchenko M. S. Clinical variants of irritable bowel syndrome in children. Russian Pediatric Journal. 2020; 23 (6): 407–408. (In Russ).

4. Belmer S.V., Volynets G. V., Gurova М. М., et al. Draft clinical guidelines of the Russian Society of Paediatric Gastroenterologists, Hepatologists and Nutritionists on diagnosis and treatment of functional gastrointestinal disorders in children. Vopr. det. dietol. (Pediatric Nutrition). 2019;17(6):27–48. (In Russ). doi:10.20953/1727–5784–2019–6–27–48.

5. Pechkurov Dmitry V., Turti Tatiana V., Belyaeva Irina A., Tjazheva Alena A. Intestinal Microflora in Children: from Formation Disturbances Prophylaxis to Preventing Non-Infectious Diseases. Pediatricheskaya farmakologiya – Pediatric pharmacology. 2016; 13 (4): 377–383. (In Russ). doi:10.15690/pf.v13i4.1611.

6. Uspensky Yu.P., Mirzoev O. S., Fominykh Yu.A., Ivanov S. V. Modern view on problem of combined functional diseases of gastrointestinal tract. Meditsinskiy alfavit. 2018; 7(344): 42–47. (In Russ.)

7. Khavkin A.I., Volynets G. V., Nikitin A. V. The relationship of the gut microbiome and metabolism of bile acids. Voprosy prakticheskoj pediatrii (Clinical Practice in Pediatrics). 2020; 15(1): 53–60. (In Russ.) doi:10.20953/1817–7646–2020–1–53–60.

8. Komarova О.N., Khavkin A. I. Correlation Between Stress, Immunity and Intestinal Microbiota. Pediatricheskaya farmakologiya (Pediatric pharmacology). 2020; 17(1): 18–24. (In Russ.) doi:10.15690/pf.v17i1.2078.

9. Suvorov A. N. Mir mikrobov i chelovek. [The microbial world and man.] Priroda = Nature, 2015; 5: 11–19. (In Russ.)

10. Khavkin A.I., Blat S. F. Intestinal microbiocenosis and immunity. Russian Bulletin of Perinatology and Pediatrics. 2011;56(1): 159–174. (In Russ.)

11. Bel’mer S.V., Razumovskij A.YU., Khavkin A. I., et al. Bowel disease in children. Moscow. MEDPRAKTIKA-M, 2018; 2: 496. (In Russ.)

12. Maccaferri S., Candela M., Turroni S., Centanni M., Severgnini M., Consolandi C., Cavina P., Brigidi P. IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation. Gut Microbes. 2012; 3(5): 406–13. doi:10.4161/gmic.21009.

13. Il’in V.K., Suvorov A. N., Kiryukhina N. V., et al. [Autoprobiotics as a means of preventing infectious and inflammatory diseases in humans in an artificial environment]. Vestnik RAMN. 2013; 2: 56–62. (In Russ.)

14. Ermolenko E.I., Svirido D. A., Kotyleva M. P., et al. Correction of rats intestinal dysbiosis using indigenous recombinant strains of enterococci and duration of their persistence in intestinal microbiocenosis. Experimental and Clinical Gastroenterology. 2016;(12):65–69. (In Russ.)

15. Solovieva O.I., Simanenkov V. I., Suvorov A. N., Ermolenko E. I., Shumikhina I. A., Svirido D. A. Use of probiotics and autoprobiotics in the treatment of irritable bowel syndrome. Experimental and clinical gastroenterology. 2017; 143 (7): 115–120. (In Russ.)

16. Metod autoprobioticheskoy profilaktiki i lecheniya disbioticheskikh rasstroystv. Meditsinskaya tekhnologiya. [A method of autoprobiotic prevention and treatment of dysbiotic disorders. Medical technology]. SPb. GOU DPO SPb MAPO Roszdrava, 2011. 14 p. (In Russ.)

17. Gonchar N.V., Alekhina L. A., Suvorov A. N. Probiotic strains of enterococci as a means of therapy and prevention of intestinal diseases in children. Experimental and clinical gastroenterology. 2013; 1: 74–78. (In Russ.)

18. Gonchar N.V., Lo Skiavo L. A., Suvorov A. N., Grigor`ev S.G Current technologies for preventing infectious complications in premature infants. Zhurnal infektologii. 2016; 8 (1): 32–37. (In Russ.)

19. Khavkin A. I. The microflora of the digestive tract. Moscow. Fond sotsial’noy pediatrii Publ., 2006. 416 P. (In Russ.)